**5. Conclusions**

*Tc* has been shown to contain several phytocomponents with significant anti-carcinogenic properties as elicited by the included in vitro and in vivo studies. Despite promising results in laboratory settings, the future scope of *Tc* application in cancer therapy depends primarily on the success of translating the in vitro and in vivo results on to the clinical trials. Thus, large-scale multicenter prospective studies are required to elicit the potential application of *Tc* in cancer therapy.

**Author Contributions:** Conceptualization, search strategy B.D., H.V.B., J.V.H., and A.W.H.A. Extraction of data from the included studies, analysis of the data- S.M., A.T.R., S.P. All authors were involved in drafting and editing the final manuscript.

**Funding:** This research received no external funding.

**Conflicts of Interest:** The authors declare no conflict of interest.
